Literature DB >> 19453649

Effect of polymerized-type I collagen in knee osteoarthritis. I. In vitro study.

J Furuzawa-Carballeda1, O A Muñoz-Chablé, J Barrios-Payán, R Hernández-Pando.   

Abstract

BACKGROUND: Polymerized-type I collagen (polymerized-collagen) is a down-regulator of inflammation and a tissue regenerator biodrug. The aim of this study was to evaluate its effect in co-cultures of cartilage and synovial tissue from patients with knee osteoarthritis (OA).
MATERIALS AND METHODS: Cartilage and synovial tissue from five patients with OA were co-cultured for 7 days in the presence or absence of 1% polymerized-collagen. To determine proteoglycans content, tissues were stained with alcian blue technique. Pro- and anti-inflammatory cytokines [interleukin (IL)-1beta, IL-8, IL-10, IL-12, tumour necrosis factor (TNF)-alpha, and interferon (IFN)-gamma] and tissue inhibitor of metalloproteinase (TIMP)-1 were measured in supernatants by ELISA and results were normalized by total protein concentration. Cartilage oligomeric matrix protein (COMP), type II collagen, TNF-alpha, IL-10 and Ki-67 expression were determined by immunohistochemistry.
RESULTS: Polymerized-type I collagen induced an increase of 3- to 6fold cell proliferation (Ki-67), proteoglycans content, and COMP and type II collagen expression, whereas it inhibited IL-1beta and TNF-alpha production. IL-10 levels were up-regulated in treated vs. untreated cultures. No differences were found on IL-8 or TIMP-1 levels in supernatants from polymerized-collagen-treated co-cultures when compared with untreated cultures. IL-12 and IFN-gamma were undetectable.
CONCLUSION: The addition of polymerized-type I collagen to cartilage and synovial tissue co-cultures induced up-regulation of chondrocytes proliferation and cartilage extracellular matrix proteins production (COMP, type II collagen and proteoglycans) as well as an anti-inflammatory cytokine (IL-10) and the down-modulation of pro-inflammatory cytokines (IL-1beta and TNF-alpha). It is possible that this mechanism might contribute to induce tissue regeneration and down-regulation of inflammation in OA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19453649     DOI: 10.1111/j.1365-2362.2009.02154.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

1.  Effectiveness of a novel hydrolyzed collagen formulation in treating patients with symptomatic knee osteoarthritis: a multicentric retrospective clinical study.

Authors:  Piero Volpi; Raul Zini; Franz Erschbaumer; Michelangelo Beggio; Alberto Busilacchi; Giulia Carimati
Journal:  Int Orthop       Date:  2020-05-23       Impact factor: 3.075

2.  Long-Term Effectiveness of Polymerized-Type I Collagen Intra-Articular Injections in Patients with Symptomatic Knee Osteoarthritis: Clinical and Radiographic Evaluation in a Cohort Study.

Authors:  Adrián Borja-Flores; Salvador I Macías-Hernández; Gabriela Hernández-Molina; Andric Perez-Ortiz; Eloy Reyes-Martínez; José Belzazar-Castillo de la Torre; Laura Ávila-Jiménez; María Cristina Vázquez-Bello; Marco Antonio León-Mazón; Janette Furuzawa-Carballeda; Gonzalo Torres-Villalobos; Fernanda Romero-Hernández; Cidronio Albavera-Hernández; Jesús Pérez-Correa; Hilda A Castro-Rocha
Journal:  Adv Orthop       Date:  2020-07-22

3.  Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis.

Authors:  David J Hunter; Marilyn C Pike; Beth L Jonas; Eugene Kissin; Julie Krop; Tim McAlindon
Journal:  BMC Musculoskelet Disord       Date:  2010-10-10       Impact factor: 2.362

4.  Polymerized-type I collagen downregulates inflammation and improves clinical outcomes in patients with symptomatic knee osteoarthritis following arthroscopic lavage: a randomized, double-blind, and placebo-controlled clinical trial.

Authors:  Janette Furuzawa-Carballeda; Guadalupe Lima; Luis Llorente; Carlos Nuñez-Álvarez; Blanca H Ruiz-Ordaz; Santiago Echevarría-Zuno; Virgilio Hernández-Cuevas
Journal:  ScientificWorldJournal       Date:  2012-04-01

5.  Native collagen hydrogel nanofibres with anisotropic structure using core-shell electrospinning.

Authors:  Yuka Wakuda; Shohei Nishimoto; Shin-Ichiro Suye; Satoshi Fujita
Journal:  Sci Rep       Date:  2018-04-19       Impact factor: 4.379

6.  Treatment with Hyaluronic Acid and Collagen-Polyvinylpyrrolidone Improves Extracellular Matrix Assembly for Scarring after Tracheal Resection.

Authors:  J Raúl Olmos-Zuñiga; Matilde Baltazares-Lipp; Claudia Hernández-Jiménez; Rogelio Jasso-Victoria; Miguel Gaxiola-Gaxiola; Mariana Silva-Martínez; Marco Antonio Iñiguez-García; A Ivan González-González; Juan Carlos Vázquez-Minero; Antonia Luna-Flores; Norma Solis-Alanis; Mario Enrique Baltazares-Lipp
Journal:  Biomed Res Int       Date:  2020-08-27       Impact factor: 3.411

7.  Effect of polymerised type I collagen on hyperinflammation of adult outpatients with symptomatic COVID-19.

Authors:  Silvia Méndez-Flores; Ángel Priego-Ranero; Daniel Azamar-Llamas; Héctor Olvera-Prado; Kenia Ilian Rivas-Redonda; Eric Ochoa-Hein; Andric Perez-Ortiz; Mario E Rendón-Macías; Estefano Rojas-Castañeda; Said Urbina-Terán; Luis Septién-Stute; Thierry Hernández-Gilsoul; Adrián Andrés Aguilar-Morgan; Dheni A Fernández-Camargo; Elizabeth Olivares-Martínez; Diego F Hernández-Ramírez; Gonzalo Torres-Villalobos; Janette Furuzawa-Carballeda
Journal:  Clin Transl Med       Date:  2022-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.